We’re supporting clients through every stage of their brand and product lifecycle.
Our centers of expertise span therapeutic areas, markets and geographies, and are underpinned by these four core research principles:
Mobile navigation menu modal
This white paper identifies the initiatives underway across Europe to address antimicrobial resistance and payers’ perceptions of their impact.
Chimeric antigen receptor (CAR)-T continues to take center stage as a paradigm shift in the treatment of cancer.
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma.
In this white paper we offer our perspective on how COVID-19 has influenced patient management.
Rapport is our monthly newsletter where we share our latest expertise and experience.
